Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

  • Mattia CF Prosperi1, 2,
  • Massimiliano Fabbiani1,
  • Iuri Fanti1,
  • Mauro Zaccarelli3, 4Email author,
  • Manuela Colafigli1,
  • Annalisa Mondi1,
  • Alessandro D’Avino1,
  • Alberto Borghetti1,
  • Roberto Cauda1 and
  • Simona Di Giambenedetto1
BMC Infectious Diseases201212:296

DOI: 10.1186/1471-2334-12-296

Received: 20 April 2012

Accepted: 1 November 2012

Published: 12 November 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
20 Apr 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 May 2012 Reviewed Reviewer Report - Pere Domingo
13 May 2012 Reviewed Reviewer Report - Giordano Madeddu
31 May 2012 Reviewed Reviewer Report - Nacho Suarez
7 Jul 2012 Author responded Author comments - Mauro Zaccarelli
Resubmission - Version 3
7 Jul 2012 Submitted Manuscript version 3
27 Aug 2012 Reviewed Reviewer Report - Nacho Suarez
2 Oct 2012 Author responded Author comments - Mauro Zaccarelli
Resubmission - Version 4
2 Oct 2012 Submitted Manuscript version 4
26 Oct 2012 Reviewed Reviewer Report - Nacho Suarez
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
1 Nov 2012 Editorially accepted
12 Nov 2012 Article published 10.1186/1471-2334-12-296

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Clinical Infectious Diseases, Catholic University of Sacred Heart
(2)
Emerging Pathogens Institute & Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida
(3)
Viral Immunodeficiency Unit, National Institute for Infectious Diseases “Lazzaro Spallanzani”
(4)
Clinical Department, National Institute for Infectious Diseases “Lazzaro Spallanzani”

Advertisement